SAN DIEGO – An estimated 26-33 million prescriptions for compounded, non–FDA-approved menopausal hormone therapy are filled in the United States e... More »
For many women, vasomotor symptoms, including hot flashes and night sweats, last for more years and persist longer past the final menstrual period tha... More »
The risk for developing diabetes mellitus among patients with systemic lupus erythematosus declined significantly with increasing use of hydroxychloro... More »
Elderly women in the United States who have metabolic syndrome and its related factors face an increased risk of endometrial cancer, according to an a... More »
Elderly women in the United States who have metabolic syndrome and its related factors face an increased risk of endometrial cancer, according to an a... More »
CORONADO, CALIF. – In patients with radioactive iodine–refractory differentiated thyroid cancer, those with target lesions less than 1.5 cm in siz... More »
The use of nitrogenous bisphosphonates was associated with a nearly 50% reduction in the incidence of endometrial cancer among women in the PLCO, or Prostate, Lung, Colorectal, and Ovarian Cancer...
The use of nitrogenous bisphosphonates was associated with a nearly 50% reduction in the incidence of endometrial cancer among women in the PLCO, or Prostate, Lung, Colorectal, and Ovarian Cancer...
The rate of prescribing bisphosphonates to protect the bone health of prostate cancer patients taking androgen deprivation therapy is extremely low in Ontario, even among those at high risk of...
Adults with type 2 diabetes or prediabetes in midlife had greater cognitive decline over the next 20 years than did people without diabetes, according to the findings from a large prospective cohort...